Elimination of HPV–associated oropharyngeal cancers in Nordic countries

Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium

(2019) A R Kreimer et al.   ANNALS OF ONCOLOGY

Age at first intercourse, number of partners and STI prevalence among Danish, Norwegian and Swedish women: estimates and trends from nationally representative cross‐sectional surveys of more than 100 000 women

(2019) Bo T. Hansen et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Antibody responses to cancer antigens identify patients with a poor prognosis among HPV-positive and HPV-negative head and neck squamous cell carcinoma patients

(2019) Simon Laban et al.   CLINICAL CANCER RESEARCH

Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status

(2019) Dominik S. Gangkofner et al.   INTERNATIONAL JOURNAL OF CANCER

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer

(2018) Camilla Lagheden et al.   BRITISH JOURNAL OF CANCER

Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomised trial (III)

(2018) Matti Lehtinen et al.   INTERNATIONAL JOURNAL OF CANCER

Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway

(2018) Bo T Hansen et al.   BMJ Open

SPERANZA project: HPV vaccination after treatment for CIN2+

(2018) Alessandro Ghelardi et al.   GYNECOLOGIC ONCOLOGY

Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma

(2017) Dana Holzinger et al.   INTERNATIONAL JOURNAL OF CANCER

Prophylactic immunization with human papillomavirus vaccines induces oral immunity in mice

(2017) Julie Ahn et al.   LARYNGOSCOPE

Characterization of human papillomavirus antibodies in individuals with head and neck cancer

(2016) Krystle A. Lang Kuhs et al.   Cancer Epidemiology

Concepts and pitfalls in measuring and interpreting attributable fractions, prevented fractions, and causation probabilities

(2015) Sander Greenland   ANNALS OF EPIDEMIOLOGY

Human Papillomavirus Antibodies and Future Risk of Anogenital Cancer: A Nested Case-Control Study in the European Prospective Investigation Into Cancer and Nutrition Study

(2015) Aimée R. Kreimer et al.   JOURNAL OF CLINICAL ONCOLOGY

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection

(2015) Daniel C. Beachler et al.   JNCI-Journal of the National Cancer Institute

Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial

(2015) Matti Lehtinen et al.   VACCINE

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection

(2015) Daniel C. Beachler et al.   JNCI-Journal of the National Cancer Institute

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)?

(2013) Woo Dae Kang et al.   GYNECOLOGIC ONCOLOGY

Clinical trials of human papillomavirus vaccines and beyond

(2013) Matti Lehtinen et al.   Nature Reviews Clinical Oncology

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

(2013) Rolando Herrero et al.   PLoS One

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

(2011) Anna R. Giuliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cervical cancer incidence can increase despite HPV vaccination

(2010) Diane M Harper et al.   LANCET INFECTIOUS DISEASES